Efficacy and safety of dinaciclib vs ofatumumab in patients with relapsed/refractory chronic lymphocytic leukemia

被引：72

作者：

Ghia, Paolo ^{[1
,2
]}

Scarfo, Lydia ^{[1
,2
]}

Perez, Susan ^{[3
]}

Pathiraja, Kumudu ^{[3
]}

Derosier, Martha ^{[3
]}

Small, Karen ^{[3
]}

Sisk, Christine McCrary ^{[3
]}

Patton, Nigel ^{[4
]}

机构：

[1] Univ Vita Salute San Raffaele, Via Olgettina 58, I-20132 Milan, Italy

[2] IRCCS Ist Sci San Raffaele, Milan, Italy

[3] Merck & Co Inc, Kenilworth, NJ USA

[4] Auckland City Hosp, Auckland, New Zealand

来源：

BLOOD | 2017年 / 129卷 / 13期

关键词：

DEPENDENT KINASE INHIBITOR; SCH; 727965; CANCER; FLAVOPIRIDOL; FLUDARABINE; CELLS; MALIGNANCIES; APOPTOSIS; IBRUTINIB; SCHEDULE;

D O I：

10.1182/blood-2016-10-748210

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1876 / 1878

页数：3

共 50 条

[21] Is this the end for immunochemotherapy in relapsed/refractory chronic lymphocytic leukemia? [J].

Robak, Tadeusz .

LEUKEMIA & LYMPHOMA, 2023, 64 (05) :907-909

[22] Venetoclax: A Review in Relapsed/Refractory Chronic Lymphocytic Leukemia [J].

Scott, Lesley J. .

TARGETED ONCOLOGY, 2019, 14 (05) :493-504

[23] Efficacy and Safety of Tirabrutinib and Idelalisib With or Without Obinutuzumab in Relapsed Chronic Lymphocytic Leukemia [J].

Kutsch, Nadine ;

Pallasch, Christian ;

Decker, Thomas ;

Hebart, Holger ;

Chow, Kai Uwe ;

Graeven, Ullrich ;

Kisro, Jens ;

Kroeber, Alexander ;

Tausch, Eugen ;

Fischer, Kirsten ;

Fink, Anna-Maria ;

Wendtner, Clemens-Martin ;

Ritgen, Matthias ;

Stilgenbauer, Stephan ;

Zhang, Danjie ;

Li, Biao ;

Jurgensmeier, Juliane M. ;

Rajakumaraswamy, Nishanthan ;

Bhargava, Pankaj ;

Hallek, Michael ;

Eichhorst, Barbara .

HEMASPHERE, 2022, 6 (06)

[24] Phase II Study of Dasatinib in Relapsed or Refractory Chronic Lymphocytic Leukemia [J].

Amrein, Philip C. ;

Attar, Eyal C. ;

Takvorian, Tak ;

Hochberg, Ephraim P. ;

Ballen, Karen K. ;

Leahy, Kathleen M. ;

Fisher, David C. ;

LaCasce, Ann S. ;

Jacobsen, Eric D. ;

Armand, Philippe ;

Hasserjian, Robert P. ;

Werner, Lillian ;

Neuberg, Donna ;

Brown, Jennifer R. .

CLINICAL CANCER RESEARCH, 2011, 17 (09) :2977-2986

[25] Fludarabine, cyclophosphamide and lenalidomide in patients with relapsed/refractory chronic lymphocytic leukemia. A multicenter phase I-II GIMEMA trial [J].

Mauro, Francesca R. ;

Carella, Angelo M. ;

Molica, Stefano ;

Paoloni, Francesca ;

Liberati, Anna M. ;

Zaja, Francesco ;

Belsito, Valeria ;

Cortellezzi, Agostino ;

Rizzi, Rita ;

Tosi, Patrizia ;

Spriano, Mauro ;

Ferretti, Antonietta ;

Nanni, Mauro ;

Marinelli, Marilisa ;

De Propris, Maria S. ;

Orlando, Sonia M. ;

Vignetti, Marco ;

Cuneo, Antonio ;

Guarini, Anna R. ;

Foa, Robin .

LEUKEMIA & LYMPHOMA, 2017, 58 (07) :1640-1647

[26] Improved efficacy and safety of zanubrutinib versus ibrutinib in patients with relapsed/refractory chronic lymphocytic leukemia (R/R CLL) in China: a subgroup of ALPINE [J].

Zhou, Keshu ;

Wang, Tingyu ;

Pan, Ling ;

Xu, Wei ;

Jin, Jie ;

Zhang, Wei ;

Hu, Yu ;

Hu, Jianda ;

Feng, Ru ;

Li, Ping ;

Liu, Zhougang ;

Liu, Peng ;

Jing, Hongmei ;

Gao, Sujun ;

Zhang, Huilai ;

Yu, Kang ;

Wang, Zhao ;

Zhu, Xiongpeng ;

Sun, Zimin ;

Li, Fei ;

Yan, Dongmei ;

Weng, Jianyu ;

Fu, Lina ;

Wang, Liping ;

Salmi, Tommi ;

Wu, Kenneth ;

Qiu, Lugui .

ANNALS OF HEMATOLOGY, 2024, 103 (10) :4183-4191

[27] Flavopiridol treatment of patients aged 70 or older with refractory or relapsed chronic lymphocytic leukemia is a feasible and active therapeutic approach [J].

Stephens, Deborah M. ;

Ruppert, Amy S. ;

Blum, Kristie ;

Jones, Jeffrey ;

Flynn, Joseph M. ;

Johnson, Amy J. ;

Ji, Jia ;

Phelps, Mitch A. ;

Grever, Michael R. ;

Byrd, John C. .

HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2012, 97 (03) :423-427

[28] The role of idelalisib in the treatment of relapsed and refractory chronic lymphocytic leukemia [J].

Nair, Kruti Sheth ;

Cheson, Bruce .

THERAPEUTIC ADVANCES IN HEMATOLOGY, 2016, 7 (02) :69-84

[29] Efficacy and Safety of the Combination of Tirabrutinib and Entospletinib With or Without Obinutuzumab in Relapsed Chronic Lymphocytic Leukemia [J].

Kutsch, Nadine ;

Pallasch, Christian ;

Tausch, Eugen ;

Boehme, Volkmar ;

Ritgen, Matthias ;

Liersch, Ruediger ;

Wacker, Alexander ;

Jacobs, Georg ;

Trappe, Ralf Ulrich ;

Dreger, Peter ;

Fischer, Kirsten ;

Fink, Anna-Maria ;

Stilgenbauer, Stephan ;

Zhai, Shuyan ;

Li, Biao ;

Jurgensmeier, Juliane M. ;

Rajakumaraswamy, Nishanthan ;

Bhargava, Pankaj ;

Hallek, Michael ;

Eichhorst, Barbara F. .

HEMASPHERE, 2022, 6 (04)

[30] Predictive significance of selected gene mutations in relapsed and refractory chronic lymphocytic leukemia patients treated with ibrutinib [J].

Machnicki, Marcin M. ;

Gorniak, Patryk ;

Pepek, Monika ;

Szymczyk, Agnieszka ;

Iskierka-Jazdzewska, Elzbieta ;

Steckiewicz, Pawel ;

Bluszcz, Aleksandra ;

Rydzanicz, Malgorzata ;

Hus, Marek ;

Ploski, Rafal ;

Makuch-Lasica, Hanna ;

Nowak, Grazyna ;

Juszczynski, Przemyslaw ;

Jamroziak, Krzysztof ;

Stoklosa, Tomasz ;

Pula, Bartosz .

EUROPEAN JOURNAL OF HAEMATOLOGY, 2021, 106 (03) :320-326

← 1 2 3 4 5 →